ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.Play
ICON offers the knowledge, software, systems and global footprint to make global adaptive trials a reality.
ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
ICON provides a range of integrated services that cover the planning, management, execution and analysis of Phase II – IIIb trials.
ICON provides insight on strategies and execution for long-term value to maximise products’ success
ICON Consulting Services provides strategic analysis to support improved decision-making in drug and device development.
ICON specialises in the strategy and delivery of early phase clinical development.
ICON is redefining FSP to provide sponsors with flexibility to meet the demands of modern drug development.
ICON provides federal and NGO clients with development and staffing services across areas such as vaccines, biothreats response and working in Africa.
ICON Medical Imaging provides medical imaging based product development services that expedite drug development.
ICON provides laboratory services through our Global Central Laboratory and Bioanalytical Laboratories.
ICON understands the unique requirements of medical devices, diagnostics, and combination drug/device and biologic/device products.
ICON provides full-spectrum resourcing solutions extending from contingent staffing to functional resourcing.